Authors
Loading...
Randomized trial investigates IGFBP1's impact on esophageal cancer progression, suggesting its potential as a therapeutic target.
Zuo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: